Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Lymphoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

X-Rays 4Phantoms, Imaging 4Specimen Handling 3Magnetic Resonance Spectroscopy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2ivosidenib 2Vemurafenib 2Triptorelin Pamoate 2Nuclear Medicine Department, Hospital 2LY3023414 2Drug Therapy 2surufatinib 1olaparib 1larotrectinib 1fludarabine 1erdafitinib 1ensartinib 1copanlisib 1bempegaldesleukin 1Zoledronic Acid 1Stem Cell Transplantation 1Sirolimus 1Proton Therapy 1Pharmacogenomic Variants 1Nivolumab 1Methionine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Indocyanine Green × Lymphoid × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡